University of Manchester: Drug Hope for People With Common Heart Thickening Disease
July 17, 2026
July 17, 2026
MANCHESTER, England, July 17 (TNSjou) -- The University of Manchester issued the following news release:
* * *
Drug hope for people with common heart thickening disease
A new drug offers hope for people with hypertrophic cardiomyopathy, the world's most common inherited heart disease.
The TEMPEST trial led by University of Manchester researchers tested the drug - called trientine - in 154 adults with the condition in a year long, placebo c . . .
* * *
Drug hope for people with common heart thickening disease
A new drug offers hope for people with hypertrophic cardiomyopathy, the world's most common inherited heart disease.
The TEMPEST trial led by University of Manchester researchers tested the drug - called trientine - in 154 adults with the condition in a year long, placebo c . . .